[1
]
Department of Dermatology, CHU Lyon, Université Claude Bernard Lyon I, 69000 Lyon,
France.
[2
]
Sorbonne université, Faculté de médecine, Service de Dermatologie et Allergologie,
Hôpital Tenon, AP-HP, 75020 Paris, France.
[3
]
Department of Dermatology, Hôpital Saint-Louis, AP-HP Université de Paris, 75010 Paris,
France.
[4
]
Pathology Department, Hôpital Saint-Louis, AP-HP, Université de Paris, Inserm U976,
75010 Paris, France.
[5
]
CEREO (National reference center for Hypereosinophilic Syndromes), 75010 Paris, France;
Department of Internal Medicine, CHU Lille, 59000 Lille, France.
[6
]
Pathology Department, CHU Lille, 59000 Lille, France.
[7
]
Dermatology Department, CHU Nantes, 44000 Nantes, France.
[8
]
Pathology Department, CHU, 44000 Nantes, France.
[9
]
Dermatology Department, Hôpital Bichat, 75018 Paris, France.
[10
]
Pathology Department, Hôpital Bichat, 75018 Paris, France.
[11
]
Faculté de Santé de Créteil et Service de Dermatologie, APHP, Hôpital Henri-Mondor,
Université Paris-Est, Créteil, France and Research Group Dynamic, EA7380, Faculté
de Santé de Créteil, Ecole Nationale Vétérinaire d'Alfort, USC ANSES, Université Paris-Est
Créteil, 94010 Créteil, France.
[12
]
Pathology Department, Hôpital Mondor, CHU Créteil, 94010 Créteil, France.
[13
]
CEREO (National reference center for Hypereosinophilic Syndromes), 75010 Paris, France;
Department of Internal Medicine, Hôpital Foch, 92150 Suresnes, France.
[14
]
Pathology Department, Hôpital Foch, 92150 Suresnes, France.
[15
]
Department of Dermatology, CHU Lille, Inserm U1286 INFINITE (Institute for Translational
Research in Inflammation), University Lille, 59000 Lille, France.
[16
]
Department of Dermatology, CHU Lyon, Université Claude Bernard Lyon I, 69000 Lyon,
France. Electronic address: axel.villani@chu-lyon.fr.